Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02094118 · ClinicalTrials.gov registry record · Phase 1
Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 171
- Enrollment target
NCT02094118: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT02094118 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 171 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (185% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02094118, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 171 participants
- Enrollment target
Study Summary
This study is designed to determine if point-of-care washing of allogeneic Leukocyte-Reduced Red Blood Cells reduces pulmonary complications when compared to standard-of-care Leukocyte-Reduced Red Blood Cells in a cardiac surgical population.
Primary Outcome
This panel of biomarkers measures inflammation, altered coagulation, and endothelial activation all of which play key roles in the pathogenesis of lung injury.
Interventions
- BIOLOGICAL Point-of-care washed red blood cell transfusion.
- BIOLOGICAL Standard of care red blood cell transfusion.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2016-01 |
| Est. Completion | 2019-05-30 |
| Phase | Phase 1 |
What the finished NCT02094118 record still lists
NCT02094118 is an interventional study that assigns participants to a tested intervention. The registered 171 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (185% higher).
The record links to 0 conditions, and to 2 interventions - of which Point-of-care washed red blood cell transfusion. is the first listed.
NCT02094118 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02094118 about?
NCT02094118 is a clinical study titled "Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications". This study is designed to determine if point-of-care washing of allogeneic Leukocyte-Reduced Red Blood Cells reduces pulmonary complications when compared to standard-of-care Leukocyte-Reduced Red Blood Cells in a cardiac surgical population.
What is the current status of trial NCT02094118?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 171 participants. The study started on 2016-01. Estimated completion is 2019-05-30.
What interventions are being tested in trial NCT02094118?
The interventions under investigation include: Point-of-care washed red blood cell transfusion. (BIOLOGICAL), Standard of care red blood cell transfusion. (BIOLOGICAL).
Who is sponsoring clinical trial NCT02094118?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02094118's enrollment target sits among peer trials
171 324th of 2000 higher than 1,676 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02641145 · 171 participants · NA
Molecular Imaging of Primary Amyloid Cardiomyopathy
- NCT05541029 · 171 participants · NA
Music Listening: A Mechanistic Trial
- NCT05561127 · 171 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
- NCT05592938 · 171 participants · NA
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia